The independent source for health policy research, polling, and news.
14,061-14,080 of 113,144 results
Meanwhile, Bloomberg reports that rates of clinical trials not related to covid are taking longer to recover in the U.K. than in some European countries. Separately, a new study shows that rates of cannabis use during early pregnancy shot up by 25% early in the pandemic.
The new drug from Biogen and partner Eisai, lecanemab, will attempt to use the same process that led to the recent approval of controversial drug Aduhelm. Meanwhile, Massachusetts' biggest health care provider, Mass General Brigham, has said it will not offer Aduhelm to patients.
Meanwhile, AP reports on the "constant barrage of misinformation" driving increased public animosity to health care workers in Idaho. Separately, Anchorage's public health manager resigns as record-level covid infections over-stretch hospitals. News outlets cover good and bad covid numbers.
At least 400,000 Americans received the Pfizer booster since it was authorized last week. The durability of immunity from a third shot is not yet known, but Pfizer CEO Albert Bourla said Tuesday that he expects protection to last around a year, Roll Call reports.
The study, published in PLOS One, shows that the vaccine support video from former President Donald Trump swayed more of his voters to get shots than a video from an expert. Separately, USA Today reports that only 18% of pregnant people in the U.S. have had a dose of covid vaccine, with notable racial disparities.
A new survey on vaccine attitudes shows what motivates people to get vaccinated. Meanwhile, the impact of requirements is reported across industries and states.
It was unclear how many workers lost their jobs or were suspended Tuesday, with some news outlets reporting "hundreds" and others saying "thousands." Regardless, disruptions were felt across the state: Some nursing homes refused new patients and hospitals warned of even longer wait times.
Stat spoke to a Biden administration official who says that key health agencies would be hit by staff shortages if the government partially shuts down next week, but that government efforts to combat covid will continue. Meanwhile, the future of Department of Transportation employees hinges on passing the infrastructure bill by Thursday.
President Joe Biden is focusing his attentions on striking a deal with Democratic Sens. Joe Manchin of West Virginia and Kyrsten Sinema of Arizona, who say the $3.5 trillion reconciliation bill is too big. Meanwhile, a progressive group of House Democrats dig in over the infrastructure bill, scheduled for a vote tomorrow. Those high-stakes negotiations are set against a tense backdrop on the Hill, where lawmakers must also come up with ways to fund the government and pay U.S. debts.
Pfizer and BioNTech provided the Food and Drug Administration with clinical trial data for kids between 5 and 11. The companies say that the tests showed that their covid vaccine is safe and effective for those ages and plans to request approval "in the coming weeks." FDA OK may not come until November though, the Wall Street Journal reports.
Today's early morning highlights from the major news organizations.
Editorial writers examine these public health topics.
Opinion pages tackle these covid and vaccine issues.
Dr. John Nkengasong, a U.S. citizen born in Cameroon, would be the first person of African descent to hold the position. The Senate must approve his eventual nomination. Other news is from Cuba, South Africa, Japan, Singapore, Hong Kong, San Marino and South Korea.
The request is part of a review of New Mexico's surface water regulations done every three years. The new testing would be more limited in detecting polychlorinated biphenyls, or PCBs, which can cause cancer, impair brain development and hurt reproductive systems.
The counterfeit pills are being made to look like real opioids such as oxycodone, Percocet or Adderall and are sold on the street by dealers or online through social media platforms, NPR says.
There were an additional 4,901 homicides last year compared with 2019, the largest leap since national records started in 1960, The New York Times says. And CBS notes that a whopping 77% of the homicides were committed with a gun, the highest percentage ever reported.
The ADA argues that Medicare won’t reimburse enough to cover their costs and seeks an alternative plan that would limit benefits to the poorest Medicare recipients, The Wall Street Journal says.
The lawsuit, filed in Massachusetts on Friday, has to do with sales for the multiple sclerosis drugs Tysabri, Avonex and Tecfidera. Also in the news: Merck, Acceleron Pharma, Valneva and Pfizer.
The French company announced Tuesday that its shot produced neutralizing antibodies against the virus in early-stage clinical trials. However, it will not proceed with Phase 3 trials because the market is already well served, said Thomas Triomphe, head of Sanofi’s vaccine business.
© 2026 KFF